CP
AGN

Cinque Partners’s Allergan plc AGN Stock Holding History

Cinque Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$203K Sell
649
-2,411
-79% -$718K 2.29% 20
2015
Q3 		$832K Hold
3,060
– – 1.41% 20
2015
Q2 		$929K Buy
3,060
+801
+35% +$239K 1.45% 20
2015
Q1 		$672K Buy
+2,259
New +$644K 1.03% 29

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Cinque Partners's AGN Position: Q4 2015 in Review

Cinque Partners reduced its Allergan plc (AGN) stake by 79% in Q4 2015, selling an estimated $718K and leaving 649 shares worth $203K. The position accounts for 2.29% of the portfolio, ranked #20.

Cinque Partners first reported a position in AGN in Q1 2015 and has held it in 4 quarters since. The position peaked at $929K in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Cinque Partners held 649 shares of Allergan plc worth $203K as of Q4 2015.
  • Cinque Partners sold 2,411 Allergan plc shares in Q4 2015, an estimated $718K.
  • Allergan plc made up 2.29% of Cinque Partners's portfolio in Q4 2015, its #20 holding.
  • Cinque Partners first reported a position in Allergan plc in Q1 2015 and has held it in 4 quarters since.
  • Cinque Partners's Allergan plc position peaked at $929K in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Cinque Partners's 13F filing for Q4 2015, filed 12 Feb 2016.